Stock Trading History of Fotiades George L

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Fotiades George L since year 2005. The trader's CIK number is 1202424. At the time of this reporting, Fotiades George L is the Director of Cantel Medical Corp . (stock ticker symbol CMN). See this page for all insider trading activities at Cantel Medical Corp .
Note that in the past FOTIADES GEORGE L also reported insider trading activities as an insider of the following companies:

Insider Activities at Cantel Medical Corp (CMN)
Insider Activities at Alberto-culver Co (ACV)
Insider Activities at Prologis (PLD)
Insider Activities at Cardinal Health Inc (CAH)

Stock purchases, sales, and option exercises reported by insider *Fotiades George L* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2008-07-01	CMN	Cantel Medical Corp	Purchase	4,000	9.96	39,840
2008-07-02	CMN	Cantel Medical Corp	Purchase	1,000	9.93	9,930
2008-06-12	CMN	Cantel Medical Corp	Purchase	4,000	11.49	45,979
2008-06-11	CMN	Cantel Medical Corp	Purchase	4,000	11.61	46,450
2007-08-20	ACV	Alberto-culver Co	Purchase	11	23.20	255
2007-05-18	ACV	Alberto-culver Co	Purchase	11	23.98	263
2007-02-20	ACV	Alberto-culver Co	Purchase	11	23.36	256
2007-11-09	PLD	Prologis	Purchase	3,000	68.00	204,000
2002-07-15	CAH	Cardinal Health Inc	Purchase	8	52.90	423
2002-04-15	CAH	Cardinal Health Inc	Purchase	6	68.70	412
2003-01-15	CAH	Cardinal Health Inc	Purchase	7	61.86	433
2002-01-15	CAH	Cardinal Health Inc	Purchase	7	61.60	431
2002-10-15	CAH	Cardinal Health Inc	Purchase	6	63.00	378
2001-10-15	CAH	Cardinal Health Inc	Purchase	5	74.00	370

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fotiades George L (Director of Cantel Medical Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.